FOXA1 and colorectal carcinoma: The analysis of FOXA1 and FOXA2 gene expression showed that while FOXA1 expression was decreased by a factor of 2–79 in 52% (23/44) of CRC samples, FOXA2 expression was increased from 2- to 23-fold in 59% (26/44) of cases.